Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7.
No abstract available

Publication types

  • Published Erratum